Cardinal Health Inc (CAH), the American multinational healthcare services company, has had mixed performance recently. Despite outperforming competitors on multiple trading days, it also experienced stock slippages following the loss of contracts with UnitedHealth's OptumRX. Nonetheless, the market perceives the company with overall positivity, as CAH passed its Q3 and Q4 earnings expectations. The firm's board of directors approved a quarterly dividend increase, but later, there was a mixed reaction to its quarterly results. The stock's value dropped following the announcement but subsequently hit a 52-week high and surged by 6.8%. CAH is considered a strong value and momentum stock, although instances of it being downgraded by StockNews.com were also reported. Apart from successful earnings, other notable events include the acquisition of Specialty Networks and its PPS Analytics platform, the reaffirmation of Fiscal 2024 non-GAAP EPS Guidance, raising of Fiscal Year 2024 Outlook, signing of new business structures, and solid business expansion. However, generally, it's evident that the stock's growth over the past five years has been significant at 171%, indicating a positive long-term outlook for investors.
Cardinal Health CAH News Analytics from Tue, 15 Aug 2023 07:00:00 GMT to Sun, 12 May 2024 15:24:18 GMT -
Rating 4
- Innovation 3
- Information 6
- Rumor 1
